Metastat Insights

Syringes Market

Syringes Market Size, Share, By Type (General Syringes, Specialized Syringes, Smart Syringes), By Usage (Disposable Syringes, Reusable Syringes), By End-User (Hospitals and Clinic, Blood Collection Centers, Others), Industry Analysis, Growth, Trends, and Forecast, 2026-2033

Report ID

MSI-2297

Published

February, 2026

Pages

310 Pages

Format
Market Size 2026
Leadership Strategies
Key Trends
Market Size 2033

Report Details

Comprehensive Market Analysis And Insights

Market Definition

A syringe is a medical device used to inject fluid inside the body and withdraw fluid outside the body. A syringe consists of a needle attached to a hollow cylinder which is fitted with a sliding plunger.

Market Dynamics

The rising prevalence of chronic diseases is booting the wearable patch market. For instance, according to the World Health Organization, the chronic disease had risen by 57% in 2020. According to the National Health Council, chronic diseases affect around 133 million Americans, representing more than 45% of the total population in 2018. According to the European Commission, Chronic diseases together account for over 86% of deaths in the European Union. According to World Health Organization (WHO), Cardiovascular diseases (CVDs) are the leading cause of death globally. About 17.9 million people die due to CVD each year, an estimate of 31% of deaths globally. More than 75% of cardiovascular disease deaths occur in lower and middle-income countries. According to the Centers for Disease Control and Prevention (CDC), in 2020, around 34.2 million people have diabetes in the United States. Further, the growing demand for vaccination and immunization is a key driving factor of the market. Vaccination and immunization have raised the demand for syringes in the global market. The outbreak of COVID-19 has raised the demand for vaccination, which will lead to the rising demand for syringes. However, product recall of syringes might hamper the market growth. For instance, Fagron Sterile Services has voluntarily recalled two lots of Neostigmine Methylsulfate 5mL syringes to the user at the hospital and clinic level. Neostigmine Methylsulfate 5mL syringes product lots were recalled because of a customer complaint that some syringe units containing Neostigmine Methylsulfate 1mg/mL, 5mg per 5mL are incorrectly labelled as Neostigmine Methylsulfate 1mg/mL, 3mg per 3mL. Moreover, rising investment for facility expansion to develop syringes would provide lucrative opportunities for the market in coming years.report image

Market Segmentation

The global syringes market is mainly classified based on type, usage, and end-use. Type is further segmented into General Syringes, Specialized Syringes, and Smart Syringes. By usage, the market is divided into Disposable Syringes and Reusable Syringes. By end-use, the market is further divided into Hospitals and Clinics, Blood Collection Centers, and Others.

Based on Type, General Syringes segment is valued at USD 12.9 billion in 2026 and is projected to reach USD 20.8 billion by 2033, at a CAGR of 7.1% during the forecast period.

Based on Usage, Disposable Syringes segment is projected to reach USD 32.9 billion by 2033, at a CAGR of 9.3% during the forecast period.

Based on End-User, Hospitals and Clinic segment is projected to reach USD 25.5 billion by 2033.

Regional Analysis

Based on geography, the global syringes market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided into the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the syringes market in 2020 owing to the increasing cases of chronic diseases, the presence of major players in this region, the collaboration between companies for the distribution of syringes in the North American market, and commercialization of prefilled syringes in the United States. For instance, Hikma Pharmaceuticals PLC, the multinational pharmaceutical company, has introduced a new prefilled syringe capability in the US through its subsidiary, Hikma Pharmaceuticals USA Inc. The company has introduced Heparin Sodium Injection prefilled syringes that are ready-to-administer that helps hospitals, pharmacists, doctors and nurses treat patients faster, and easier and with reduced risk.report image

Competitive landscape

Key players operating in the syringes industry include B. Braun Melsungen AG, Becton, Dickinson and Company, Thomas Scientific, NIPRO Medical Corporation, Smiths Medical, SCHOTT AG, Hindustan Syringes & Medical Devices Ltd., Gerresheimer AG, Terumo Corporation, and Codan Medizinische Gerate GmbH & Co Kg.

The strategic acquisition of the company to expand its geographic presence for syringes, commercialization of regulatory approved syringes, the agreement between companies for development and distribution of syringes, increasing awareness on specialized syringes, and rising investment for o expand and upgrade manufacturing capacity and technology for pre-fillable syringes are some of the strategies adopted by the major companies. For instance, on December 2, 2020, BD is planning to invest approximately $1.2 billion over a four-year period to expand and upgrade manufacturing capacity and technology for pre-fillable syringes (PFS) across six global manufacturing locations and will add a new manufacturing facility in Europe. The investment will be used for capacity expansion, manufacturing technology enhancements, new product innovations, and business continuity improvements across its existing network.

Syringes Market Key Segments:

By Type

  • General Syringes
  • Specialized Syringes
  • Smart Syringes

By Usage

  • Disposable Syringes
  • Reusable Syringes

By End-Use

Key Global Syringes Industry Players

What Report Provides

  • Key Company Market Share, Revenue, and Position/Ranking
  • Key Market Leaders
  • Full In-Depth Analysis of the Parent Industry
  • Industry Statistics
  • Important Changes in Market and Its Dynamics
  • Segmentation Details of the Market
  • Historical, On-Going, and Projected Market Analysis
  • Assessment of Niche Industry Developments
  • Market Share Analysis
  • Key Strategies of Major Players
  • Company Profiles of Key Players
  • Unique Selling Prepositions of Leading Market Players
  • Emerging Segments and Regional Growth Potential
  • Key Strategic Recommendations
  • Competitive Benchmarking
  • Import Export Trade Statistics
End of Report Overview

Frequently Asked Questions

Find answers to common questions about this report

Top players operating in the Syringes industry includes B. Braun Melsungen AG, Becton, Dickinson and Company, Thomas Scientific, NIPRO Medical Corporation, Smiths Medical, SCHOTT AG, Hindustan Syringes & Medical Devices Ltd., Gerresheimer AG, Terumo Corporation, Codan Medizinische Gerate GmbH & Co Kg.

According to Metastat Insights analysis, the North America Syringes market size is estimated to reach USD 11.8 billion by 2033.

The Syringes market is estimated to reach a valuation of USD 36.6 billion by 2033.

The Metastat Insights study reveals that the Syringes market size was valued at USD 18.9 billion in 2025.

The Syringes market is projected to grow at a CAGR of 8.6% during the forecast period from 2026 to 2033.

Healthcare Research Team

The analysts below cover Healthcare research at Metastat Insights.

UTKARSH KHIRODKAR

LEAD ANALYST

Utkarsh Khirodkar is a Lead Market Research Analyst at MetaStat Insight, specializing in market intelligence, technology sector assessments, and competitive strategy.

AJAY DEVGIRE

LEAD PRINCIPAL ANALYST, PHARMA AND HEALTHCARE

Food and Beverages · Healthcare · Healthcare IT · Medical Devices

Ajay Devgire is the Lead Healthcare Analyst at MetaStat Insight, leading strategic research and market intelligence initiatives across the global healthcare domain.

What our clients say

Most industry reports on warehouse automation bundle autonomous mobile robots and fixed conveyor installations into the same top-level numbers, which complicates advisory work. This study split the market cleanly by payload tiers, navigation technology, and fleet management software layers. The regional forecast for Western Europe gave our team defensible adoption benchmarks when evaluating capital allocation for logistics clients, saving us days of secondary data scrubbing.
D

Deloitte

Principal Consultant, Supply Chain and Network Operations

Analyzing the transition from natural gas to green hydrogen in iron ore reduction requires realistic infrastructure timelines. Meta stat insight supplied a detailed regional assessment of DRI plant conversion costs and scrap metal availability in North America and Western Europe. Their report carefully examined pellet quality specs and electrical grid access constraints without making oversimplified market assumptions. The research material served as a practical reference during internal technology roadmap discussions.
A

ArcelorMittal

Head of Metallurgical Processes

Integrating zero-trust access controls across legacy electronic health record systems involves complex compliance overhead. Team produced an analysis that clearly separated identity governance and administration tools from privileged access management platforms. Their evaluation of HIPAA and GDPR compliance features across cloud native solutions gave our architecture group clear baseline criteria. The custom data request regarding biometric authentication adoption in hospital networks was returned promptly with clear documentation.
O

Oracle Health

CTO

Related Reports

Explore related market intelligence reports worth reading alongside this one.